Gamma Medica-Ideas has acquired Advanced Molecular Imaging to enhance its offerings in digital imaging technologies for improved diagnostics and drug discovery.

Target Company Overview

Advanced Molecular Imaging, Inc. (AMI) is a Sherbrooke, Canada-based company that specializes in the development of medical devices and techniques for molecular imaging of living subjects. AMI is renowned for its cutting-edge pre-clinical imaging products, particularly its fully digital Avalanche PhotoDiode (APD) Positron Emission Tomography (PET) product. This innovative technology offers a cost-effective solution for molecular imaging, delivering exceptional performance by integrating traditional imaging modalities such as CT and PET scanning.

AMI’s proprietary technologies are particularly focused on enhancing pre-clinical research and clinical diagnostics within the pharmaceutical industry. With a strong partnership with the Université de Sherbrooke leading to the advancement of their APD detector technology, AMI holds considerable potential in the growing field of molecular imaging.

Industry Overview in Canada

The medical imaging sector in Canada is part of a dynamic healthcare industry characterized by rapid technological advancements and increasing demand for early disease diagnosis. This growth is driven by an aging population, rising hea